Lifetime Medical Costs of Knee Osteoarthritis Management in the United States: Impact of Extending Indications for Total Knee Arthroplasty

The impact of increasing utilization of total knee arthroplasty (TKA) on lifetime costs in persons with knee osteoarthritis (OA) is understudied.

[1]  P. Dieppe,et al.  Associations between pre-operative radiographic changes and outcomes after total knee joint replacement for osteoarthritis. , 2012, Osteoarthritis and cartilage.

[2]  M. Liang,et al.  Costs and outcomes in rheumatoid arthritis and osteoarthritis. , 1984, Arthritis and rheumatism.

[3]  G. Naglie,et al.  The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis. , 2003, Arthritis and rheumatism.

[4]  N. Mahomed,et al.  Predicting Patient Dissatisfaction Following Joint Replacement Surgery , 2008, The Journal of Rheumatology.

[5]  S. Willich,et al.  Quality of life and cost-effectiveness of acupuncture treatment in patients with osteoarthritis pain , 2008, The European Journal of Health Economics.

[6]  F. Silverstein,et al.  Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor , 2000, American Journal of Gastroenterology.

[7]  R. Marx,et al.  Treatment of osteoarthritis of the knee (nonarthroplasty). , 2009, The Journal of the American Academy of Orthopaedic Surgeons.

[8]  M. Shainline,et al.  Hospital, pharmacy, and outpatient costs for osteoarthritis and chronic back pain. , 2004, The Journal of rheumatology.

[9]  J. Jordan,et al.  Lifetime Risk and Age at Diagnosis of Symptomatic Knee Osteoarthritis in the US , 2013, Arthritis care & research.

[10]  S. Gabriel,et al.  Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. , 2008, Arthritis and rheumatism.

[11]  J. Jordan,et al.  Forecasting the burden of advanced knee osteoarthritis over a 10-year period in a cohort of 60-64 year-old US adults. , 2011, Osteoarthritis and cartilage.

[12]  Jh. Kellgren.  Radiological assessment of osteoarthrosis , 1957 .

[13]  G. Nappi,et al.  Clinical efficacy and cost-effectiveness evidence of spa therapy in osteoarthritis. The results of "Naiade" Italian Project. , 2003, Panminerva medica.

[14]  T. V. Vliet Vlieland,et al.  Patients with Severe Radiographic Osteoarthritis Have a Better Prognosis in Physical Functioning after Hip and Knee Replacement: A Cohort-Study , 2013, PloS one.

[15]  J. Katz,et al.  Placing a Price on Medical Device Innovation: The Example of Total Knee Arthroplasty , 2013, PloS one.

[16]  D. Felson,et al.  Consistency of Knee Pain and Risk of Knee Replacement: The Multicenter Osteoarthritis Study , 2011, The Journal of Rheumatology.

[17]  G. Oster,et al.  Direct and Indirect Economic Costs Among Private-Sector Employees With Osteoarthritis , 2011, Journal of occupational and environmental medicine.

[18]  J. Kellgren,et al.  Radiological Assessment of Osteo-Arthrosis , 1957, Annals of the rheumatic diseases.

[19]  N. Dreyer,et al.  Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting: the importance of drug and surgery costs. , 1997, Arthritis and rheumatism.

[20]  Teemu Moilanen,et al.  Younger age increases the risk of early prosthesis failure following primary total knee replacement for osteoarthritis , 2010, Acta orthopaedica.

[21]  E. Cook,et al.  The importance of patient expectations in predicting functional outcomes after total joint arthroplasty. , 2002, The Journal of rheumatology.

[22]  R. Marx,et al.  Risk Factors for Revision Within 10 Years of Total Knee Arthroplasty , 2014, Clinical orthopaedics and related research.

[23]  J. Katz,et al.  The dramatic increase in total knee replacement utilization rates in the United States cannot be fully explained by growth in population size and the obesity epidemic. , 2012, The Journal of bone and joint surgery. American volume.

[24]  N Mahomed,et al.  Outcomes of total hip and knee replacement: preoperative functional status predicts outcomes at six months after surgery. , 1999, Arthritis and rheumatism.

[25]  M. Weinstein,et al.  Recommendations of the Panel on Cost-effectiveness in Health and Medicine. , 1996, JAMA.

[26]  D. König,et al.  Pre-operative arthritis severity as a predictor for total knee arthroplasty patients’ satisfaction , 2013, International Orthopaedics.

[27]  J. Senior,et al.  Misoprostol Reduces Serious Gastrointestinal Complications in Patients with Rheumatoid Arthritis Receiving Nonsteroidal Anti-Inflammatory Drugs , 1995, Annals of Internal Medicine.

[28]  P. Sanelli,et al.  Hospital Outpatient Prospective Payment System , 2012, American Journal of Neuroradiology.

[29]  Atlanta,et al.  Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. , 2008, Arthritis and rheumatism.

[30]  J. Clouse,et al.  Implications of controlling for comorbid conditions in cost-of-illness estimates: a case study of osteoarthritis from a managed care system perspective. , 2001, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[31]  J. Raynauld,et al.  Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. , 2003, Arthritis and rheumatism.

[32]  A. Eskelinen,et al.  Comparison of survival and cost‐effectiveness between unicondylar arthroplasty and total knee arthroplasty in patients with primary osteoarthritis: A follow‐up study of 50,493 knee replacements from the Finnish Arthroplasty Register , 2008, Acta orthopaedica.

[33]  Sally C. York,et al.  Long-term follow-up care recommendations after total hip and knee arthroplasty: results of the American Association of Hip and Knee Surgeons' member survey. , 2003, The Journal of arthroplasty.

[34]  Elizabeth W Paxton,et al.  A prospective study of 80,000 total joint and 5000 anterior cruciate ligament reconstruction procedures in a community-based registry in the United States. , 2010, The Journal of bone and joint surgery. American volume.

[35]  P. Isakson,et al.  Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial. , 1999, Mayo Clinic proceedings.

[36]  Rosalind J Wright,et al.  Association between hospital and surgeon procedure volume and the outcomes of total knee replacement. , 2004, The Journal of bone and joint surgery. American volume.

[37]  M. Lai,et al.  Cost-effectiveness of treatment strategies for osteoarthritis of the knee in Taiwan. , 2004, The Journal of rheumatology.

[38]  Jeffrey N Katz,et al.  Timing of total joint replacement affects clinical outcomes among patients with osteoarthritis of the hip or knee. , 2002, Arthritis and rheumatism.

[39]  M. Keith,et al.  American Academy of Orthopaedic Surgeons clinical practice guideline on the treatment of osteoarthritis (OA) of the knee. , 2010, The Journal of bone and joint surgery. American volume.

[40]  J. Dekker,et al.  The cost effectiveness of behavioural graded activity in patients with osteoarthritis of hip and/or knee , 2006, Annals of the rheumatic diseases.

[41]  P Tugwell,et al.  OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. , 2010, Osteoarthritis and cartilage.

[42]  S. Gabriel,et al.  The cost-effectiveness of acetaminophen, NSAIDs, and selective COX-2 inhibitors in the treatment of symptomatic knee osteoarthritis. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[43]  Lisa I. Iezzoni,et al.  Risk Adjustment of Medicare Capitation Payments Using the CMS-HCC Model , 2004, Health care financing review.

[44]  R H Brook,et al.  Costs attributable to osteoarthritis. , 1998, The Journal of rheumatology.

[45]  S. Kong,et al.  Incremental Cost-Effectiveness Analysis Comparing Rofecoxib with Nonselective NSAIDs in Osteoarthritis , 2012, PharmacoEconomics.

[46]  Elena Losina,et al.  Association of hospital and surgeon procedure volume with patient-centered outcomes of total knee replacement in a population-based cohort of patients age 65 years and older. , 2007, Arthritis and rheumatism.

[47]  Gordon Guyatt,et al.  American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee , 2012, Arthritis care & research.

[48]  Thomas E Novotny,et al.  US Department of Health and Human Services: a need for global health leadership in preparedness and health diplomacy. , 2006, American journal of public health.

[49]  A David Paltiel,et al.  Cost-effectiveness of total knee arthroplasty in the United States: patient risk and hospital volume. , 2009, Archives of internal medicine.

[50]  F. Desmeules,et al.  Determinants of pain, functional limitations and health-related quality of life six months after total knee arthroplasty: results from a prospective cohort study , 2013, Sports Medicine, Arthroscopy, Rehabilitation, Therapy & Technology.

[51]  X. Ayral.  Injections in the treatment of osteoarthritis. , 2001, Best practice & research. Clinical rheumatology.

[52]  S. Gabriel,et al.  Costs of osteoarthritis: estimates from a geographically defined population. , 1995, The Journal of rheumatology. Supplement.

[53]  J. Kopec,et al.  After patients are diagnosed with knee osteoarthritis, what do they do? , 2010, Arthritis care & research.

[54]  J. Pope,et al.  The efficacy and cost effectiveness of N of 1 studies with diclofenac compared to standard treatment with nonsteroidal antiinflammatory drugs in osteoarthritis. , 2004, The Journal of rheumatology.

[55]  V. Preedy,et al.  National Health and Nutrition Examination Survey , 2010 .

[56]  True difference or something else? Problems in cost of osteoarthritis studies. , 2007, Seminars in arthritis and rheumatism.

[57]  P. Deb,et al.  Comparison of Medicare Spending and Outcomes for Beneficiaries with Lower Extremity Joint Replacements , 2005 .

[58]  B. Morrey.  A Prospective Study of 80,000 Total Joint and 5000 Anterior Cruciate Ligament Reconstruction Procedures in a Community-Based Registry in the United States , 2011 .

[59]  Thomas J. Schnitzer,et al.  Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update , 2000 .

[60]  A. Woolf,et al.  The long-term effects of non-steroidal anti-inflammatory drugs in osteoarthritis of the knee: a randomized placebo-controlled trial. , 2000, Rheumatology.

[61]  H. Sharifi,et al.  Cost-effectiveness analysis of unicompartmental knee arthroplasty as an alternative to total knee arthroplasty for unicompartmental osteoarthritis. , 2006, The Journal of bone and joint surgery. American volume.

[62]  D. Liew,et al.  The impact of pre-operative obesity on weight change and outcome in total knee replacement: a prospective study of 529 consecutive patients. , 2010, The Journal of bone and joint surgery. British volume.

[63]  Elena Losina,et al.  Estimating the burden of total knee replacement in the United States. , 2013, The Journal of bone and joint surgery. American volume.

[64]  Rochelle P. Walensky,et al.  Impact of Obesity and Knee Osteoarthritis on Morbidity and Mortality in Older Americans , 2011, Annals of Internal Medicine.

[65]  Marc A Pfeffer,et al.  Cardiovascular Risk Associated With Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention , 2005, The New England journal of medicine.

[66]  M. Sevick,et al.  Cost-effectiveness of exercise and diet in overweight and obese adults with knee osteoarthritis. , 2009, Medicine and science in sports and exercise.

[67]  J. Dekker,et al.  Factors contributing to possession and use of walking aids among persons with rheumatoid arthritis and osteoarthritis. , 2003, Arthritis and rheumatism.

[68]  P Tugwell,et al.  OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. , 2008, Osteoarthritis and cartilage.

[69]  W M O'Fallon,et al.  Direct medical costs unique to people with arthritis. , 1997, The Journal of rheumatology.

[70]  Alan G. White,et al.  Direct and Indirect Costs of Pain Therapy for Osteoarthritis in an Insured Population in the United States , 2008, Journal of occupational and environmental medicine.

[71]  M. Sevick,et al.  Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: the Arthritis, Diet, and Activity Promotion Trial. , 2004, Arthritis and rheumatism.